World journal of urology

Prioritization of risk situations in neuro-urology: guidelines from Association Française d'Urologie (AFU), Association Francophone Internationale des Groupes d'Animation de la Paraplégie (A.F.I.G.A.P.), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d'UroDynamique et de Pelvi-Périnéologie (SIFUD-PP)

2022Regional

Europe

Read the PDF Original at the sourceAsk Osler about this guideline

Read the guideline

Full text, typeset by Prognia18 KBOpen in a new tab Download

Open the PDF

Abstract

Ask a question about this guideline.

Osler answers from this library and names the guideline behind every claim.

Discover Osler

The current health crisis has drastically impacted patient management in many fields, including neuro-urology, leading to a mandatory reorganization. The aim of this work was to establish guidelines regarding the prioritization and optimal timing of each step of neurogenic lower urinary tract dysfunction management.

A steering committee included urologists and physical medicine and rehabilitation practitioners. Based on a literature review and their own expertise, they established a comprehensive risk-situation list and built a risk scale, allowing multiple other experts to score each clinical situation. New recommendations were generated using a Delphi process approach.

Forty-nine experts participated in the rating group. Among the 206 initial items, 163 were selected and divided into four domains, diagnosis and assessment, treatment, follow-up, and complications, and two sub-domains, general (applicable for all neurological conditions) and condition-specific [varying according to the neurological condition (spinal cord injury, multiple sclerosis, brain injury, Parkinsonism, dysraphism, lower motor neuron lesions)]. The resulted guidelines are expert opinions established by a panel of French-speaking specialists, which could limit the scalability of this work.

The present multidisciplinary collaborative work generates recommendations which complement existing guidelines and help clinicians to reorganize their patients' list in the long term with a personalized medicine approach, in the context of health crisis or not.

Source and rights

Published by World journal of urology, 2022. The PDF is shown as published and remains the work of its authors and publisher; the original is at the source linked here. Rights holders can ask us to remove a file at info@prognia.nl.

pmc.ncbi.nlm.nih.gov/articles/PMC8369873/

Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.

At a glance

Published: 2022
Applies to: 🇪🇺 Europe
Scope: Regional
Journal: World journal of urology
DOI: 10.1007/s00345-021-03804-4
PubMed: 34402945
PubMed Central: PMC8369873
Added to Prognia: 22 July 2026

BLEFCO 2026

Recommendations for Human Sperm Morphology Assessment in 2025: An Expert Review From the French BLEFCO GroupBLEFCO Group · 2026Added 18 Jul 2026PDF

Vasectomy: AUA Guideline (2026) Part I.American Urological Association · 2026Added 17 Jul 2026PDF

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part III: Procedural/Surgical ManagementAmerican Urological Association · 2026Added 16 Jul 2026PDF

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part II: Medical ManagementAmerican Urological Association · 2026Added 16 Jul 2026PDF

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part I: Presentation and EvaluationAmerican Urological Association · 2026Added 16 Jul 2026PDF

European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 GuidelinesEuropean Association of Urology · 2026Added 17 Jul 2026

Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering CommitteeAmerican College of Radiology · 2026Added 16 Jul 2026

Varicocele Treatment in Azoospermia Before Artificial Reproductive Techniques: Critical Considerations by the EAU Guidelines Panel on Sexual and Reproductive HealthEuropean Association of Urology · 2026Added 16 Jul 2026

Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer GroupInternational Bladder Cancer Group · 2026Added 16 Jul 2026

Preoperative urine culture in urology: Indications and management - The 2026 French guidelinesThe French journal of urology · 2026Added 16 Jul 2026